跳至主要内容
临床试验/NCT04777643
NCT04777643已完成早期 1 期

Sex Differences in Neural Response to Cannabidiol

Yale University1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2022年6月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
19
试验地点
1
主要终点
Amygdala activation during stress

研究概览

简要总结

This is a randomized, double-blind, within-subjects, cross-over design to assess neural changes following a single dose of cannabidiol (CBD) (600mg) versus placebo among healthy female volunteers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Female, aged 18-65
  • In good general health as evidenced by medical history and medically eligible to receive CBD, as determined by the licensed physician, Dr. Ayana Jordan
  • Body Mass Index between 18.5 and 30
  • For females of reproductive potential: agreement to use highly effective contraception during study participation and/or negative pregnancy test prior to fMRI scanning

排除标准

  • Recent use of cannabis (any past month use)
  • Lifetime history of cannabis use disorder
  • Lifetime history of chronic pain disorder
  • Current DSM-5 disorder, as determined via Structured Clinical Interview (SCID-5)
  • Presence of any contraindication to MRI scanning
  • Known allergic reactions to cannabidiol
  • Lifetime use of Epidiolex
  • Currently taking any medications that could interact with cannabidiol
  • Current smoker or tobacco use >1x/week
  • Not fluent in English
  • Less than 6th grade reading level

研究组 & 干预措施

Cannabidiol

Experimental

Participants will receive a single 600mg oral dose of Epidiolex (cannabidiol) 2 hours prior to fMRI scanning.

干预措施: Cannabidiol (Drug)

Placebo

Placebo Comparator

Participants will receive a single oral dose of placebo 2 hours prior to fMRI scanning.

干预措施: Placebo (Other)

结局指标

主要结局

Amygdala activation during stress

时间窗: fMRI will begin 2 hours post-drug administration and will last no more than 1 hour.

Participants will complete 1 fMRI scan following CBD administration and another fMRI scan following placebo administration. During each scan, participants will complete the Emotion Regulation Task (ERT). The first primary outcome measure will be amygdala response during the negative emotionality contrast of the ERT during their CBD relative to their placebo scan.

Insula activation during social exclusion

时间窗: fMRI will begin 2 hours post-drug administration and will last no more than 1 hour.

Participants will complete 1 fMRI scan following CBD administration and another fMRI scan following placebo administration. During each scan, participants will complete the Cyberball Task. The second primary outcome measure will be insula response during the exclusion versus inclusion contrast of the Cyberball Task during their CBD relative to their placebo scan.

次要结局

  • Patterns of amygdala functional connectivity during stress(fMRI will begin 2 hours post-drug administration and will last no more than 1 hour.)
  • Patterns of insula functional connectivity during social exclusion(fMRI will begin 2 hours post-drug administration and will last no more than 1 hour.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Sex Differences in Neural Response to Cannabidiol | 临床试验